Healthy adult
Conditions
Sponsors
CPCC Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Healthy males and females from 20 to 64 years of age (2) Subjects who are aware that they are susceptible to cold and flu (3) Subjects who have gotten corona virus vaccination twice at least 14 days prior to the date of obtaining consent (3) Subjects who have received sufficient explanation of this study, understands the contents, and are able to give written consent
Exclusion criteria
Exclusion criteria: (1) Subjects who regularly intake food containing involvement ingredients at least 3 times a week. (2) Subjects who constantly use supplements or drugs affecting the immune system. (3) Subjects who regularly intake food or medicines rich in lactic acid bacteria at least 3 times a week (4) Subjects who undergoing treatment affecting the outcome of the study (5) Night and day shift worker or manual laborer (6) Subjects who are habitually vigorous exercise such as marathon (7) Subjects who cannot carry out the inspection procedure of various inspection by the rule during the study period (8) Subjects are undergoing medical treatment or judged as require medical treatment (9) Subjects who have under treatment or a history of serious disease (10) Subjects who are pregnant, lactating, or intending to become pregnant during the study period (11) Subjects who are allergic to medicines and foods (12) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination (13) Subjects who are participating in other clinical trials of drug or health food, or within 4 weeks of completion of the trial, or who plan to participate in other clinical trials after agreeing to participate in the study (14) Subjects who have donated 200 mL component blood or whole blood for 1 month prior to the study (15) Men who have donated 400 mL whole blood for 3 months prior to the study (16) Women who have donated 400 mL of whole blood for 4 months prior to the study (17) Men who have donated more than 1,200 mL of blood in the 12 months prior to the study, by adding the total planned blood collection volume for the study (18) Women who have donated more than 800 mL of whole blood in the 12 months prior to the study, by adding the total planned blood volume for the study. (19) Subjects who are judged as unsuitable for the study by the principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Immune function | — |
Secondary
| Measure | Time frame |
|---|---|
| Physical condition questionnaire | — |
Countries
Japan
Contacts
Public ContactTomomi Tanaka
Kewpie Corporation R&D Division
Outcome results
None listed